We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.38B
AUM Growth
-$101M
Cap. Flow
-$196M
Cap. Flow %
-8.23%
Top 10 Hldgs %
21.35%
Holding
276
New
33
Increased
38
Reduced
163
Closed
29

Sector Composition

1 Technology 24.67%
2 Healthcare 22.79%
3 Industrials 22.78%
4 Financials 9.47%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOUR icon
26
Shift4
FOUR
$3.99B
$28.8M 1.21%
393,180
-10,575
-3% -$701K
ONTO icon
27
Onto Innovation
ONTO
$13.9B
$27.5M 1.15%
125,417
-29,835
-19% -$6.17M
MDGL icon
28
Madrigal Pharmaceuticals
MDGL
$12.8B
$27.1M 1.14%
96,764
-4,859
-5% -$1.16M
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$26.9M 1.13%
392,591
-9,020
-2% -$626K
PI icon
30
Impinj
PI
$4.21B
$26.4M 1.11%
168,597
+4,608
+3% +$685K
MOD icon
31
Modine Manufacturing
MOD
$12.2B
$26.1M 1.09%
+260,150
New +$25M
TDW icon
32
Tidewater
TDW
$3.77B
$25.7M 1.08%
270,023
+68,222
+34% +$6.73M
NEO icon
33
NeoGenomics
NEO
$1.9B
$25.6M 1.07%
1,844,615
-61,289
-3% -$869K
NSSC icon
34
Napco Security Technologies
NSSC
$1.29B
$25.4M 1.06%
488,583
+264,789
+118% +$12.1M
NVEE
35
DELISTED
NV5 Global
NVEE
$25.3M 1.06%
1,087,784
-47,740
-4% -$1.11M
AX icon
36
Axos Financial
AX
$5.66B
$25.3M 1.06%
442,086
-15,338
-3% -$834K
AGYS icon
37
Agilysys
AGYS
$3B
$25M 1.05%
240,341
-7,526
-3% -$675K
TNET icon
38
TriNet
TNET
$2.74B
$25M 1.05%
250,168
-10,031
-4% -$1.12M
MC icon
39
Moelis & Co
MC
$5.02B
$24.7M 1.04%
434,486
-18,339
-4% -$991K
LPX icon
40
Louisiana-Pacific
LPX
$5.17B
$23.9M 1%
289,697
+13,391
+5% +$1.12M
RMBS icon
41
Rambus
RMBS
$11B
$23.2M 0.97%
394,961
+30,297
+8% +$1.73M
ARHS icon
42
Arhaus
ARHS
$1.09B
$22.7M 0.95%
1,339,490
-52,193
-4% -$845K
KLIC icon
43
Kulicke & Soffa
KLIC
$5.09B
$21.8M 0.91%
443,002
+161,791
+58% +$7.61M
OLLI icon
44
Ollie's Bargain Outlet
OLLI
$4.02B
$21.5M 0.9%
219,404
+30,648
+16% +$2.44M
NOG icon
45
Northern Oil and Gas
NOG
$2.31B
$21.1M 0.88%
566,999
+84,751
+18% +$3.4M
COLL icon
46
Collegium Pharmaceutical
COLL
$1.17B
$20.9M 0.88%
650,173
-19,339
-3% -$671K
RARE icon
47
Ultragenyx Pharmaceutical
RARE
$2.88B
$20M 0.84%
486,682
-1,456
-0.3% -$62.2K
BJRI icon
48
BJ's Restaurants
BJRI
$1.42B
$19.6M 0.82%
565,212
-21,049
-4% -$722K
CHDN icon
49
Churchill Downs
CHDN
$5.85B
$19M 0.8%
136,305
-193,743
-59% -$25.4M
VAL icon
50
Valaris
VAL
$5.3B
$19M 0.8%
254,883
+28,933
+13% +$2.1M

Similar funds

Emerald Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Emerald Advisers held 276 positions worth $2.38B, down 4.1% from $2.49B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers withdrew a net $196M in Q2 2024, closing 29 positions and reducing 163 holdings. Its most notable exit was Treace Medical Concepts, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Advisers opened a new position in Modine Manufacturing worth $26.1M.

  • Emerald Advisers's largest Q2 2024 buy was Modine Manufacturing: 260,150 shares worth $26.1M.
  • Emerald Advisers added most to InterDigital in Q2 2024, an estimated $12.9M increase.
  • Emerald Advisers's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $75.9M.
  • Emerald Advisers fully exited Treace Medical Concepts in Q2 2024, selling an estimated $20.4M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.38B portfolio in Q2 2024.
  • Emerald Advisers opened 33 new positions and closed 29 in Q2 2024.
  • Emerald Advisers's portfolio value fell 4.1% quarter-over-quarter to $2.38B.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.